跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 44,612 条关于
“chronic schizophrenia”
全部
44,612
临床试验
37,906
药物
334
机构
61
资讯
6,311
2年前
Newron's Evenamide Shows Promise in Treatment-Resistant Schizophrenia
去年
FDA Approves Cobenfy, a Novel Treatment for Schizophrenia
2年前
Newron's Evenamide Shows Breakthrough Results in Treatment-Resistant Schizophrenia Phase II/III Trials
去年
Newron Pharmaceuticals Advances Pivotal Phase III Program for Treatment-Resistant Schizophrenia
去年
Clinical Outcome Assessments: A Critical Foundation for Modern Drug Development Success
去年
FDA Approves Bristol Myers Squibb's Cobenfy for Schizophrenia Treatment
去年
Cobenfy Approved for Schizophrenia: A Novel Muscarinic Receptor Agonist
去年
Deep Brain Stimulation of Hippocampus Shows Promise for Treatment-Resistant Schizophrenia in New Trial
去年
Lumateperone Shows Promise in Preventing Symptomatic Relapse in Schizophrenia
去年
LB Pharmaceuticals Files for $100 Million IPO to Advance Schizophrenia Drug LB-102 into Phase III
第 1 页,共 632 页
上一页
下一页